Benzinga | Apr 27, 2021 06:18AM EDT

Morgan Stanley Upgrades Cullinan Oncology to Overweight

Morgan Stanley analyst Jeffrey Hung upgrades Cullinan Oncology (NASDAQ:CGEM) from Equal-Weight to Overweight.